Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126394711 | 12639471 | 1 | I | 20160323 | 0 | 20160809 | 20160809 | DIR | 79.00 | YR | M | N | 175.00000 | LBS | 20160808 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126394711 | 12639471 | 1 | PS | CLINDAMYCIN HCL | CLINDAMYCIN HYDROCHLORIDE | 1 | Oral | 2 CAPSULE(S) EVERY 6 HOURS TAKEN BY MOUTH | N | D | 0 | 2 | DF | CAPSULE | Q6H | ||||
| 126394711 | 12639471 | 2 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 126394711 | 12639471 | 4 | C | LOSARTAN. | LOSARTAN | 1 | 0 | ||||||||||||
| 126394711 | 12639471 | 6 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 126394711 | 12639471 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 126394711 | 12639471 | 10 | C | ATENOLOL. | ATENOLOL | 1 | 0 | ||||||||||||
| 126394711 | 12639471 | 12 | C | DIAZEPAM. | DIAZEPAM | 1 | 0 | ||||||||||||
| 126394711 | 12639471 | 14 | C | INSULIN | INSULIN NOS | 1 | 0 | ||||||||||||
| 126394711 | 12639471 | 16 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | ||||||||||||
| 126394711 | 12639471 | 18 | C | ASA | ASPIRIN | 1 | 0 | ||||||||||||
| 126394711 | 12639471 | 20 | C | MVI | VITAMINS | 1 | 0 | ||||||||||||
| 126394711 | 12639471 | 22 | C | OMEGA-3 ACIDS | OMEGA-3 FATTY ACIDS | 1 | 0 | ||||||||||||
| 126394711 | 12639471 | 24 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | 0 | ||||||||||||
| 126394711 | 12639471 | 26 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 | ||||||||||||
| 126394711 | 12639471 | 28 | C | CALCIUM CITRATE W/VIT D | 2 | 0 | |||||||||||||
| 126394711 | 12639471 | 30 | C | GLUCOSAMINE | GLUCOSAMINE | 1 | 0 | ||||||||||||
| 126394711 | 12639471 | 32 | C | CHONDROITIN | CHONDROITIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126394711 | 12639471 | 1 | Antibiotic prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126394711 | 12639471 | LT |
| 126394711 | 12639471 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126394711 | 12639471 | Anaphylactic reaction | |
| 126394711 | 12639471 | Hypoxia | |
| 126394711 | 12639471 | Mental disorder | |
| 126394711 | 12639471 | Muscular weakness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126394711 | 12639471 | 1 | 1 | DAY |